Skip to main content
Clinical Trials/EUCTR2020-002908-39-FI
EUCTR2020-002908-39-FI
Active, not recruiting
Phase 1

Detection of paracetamol concentration in blood-, saline- and urine samples with an electrochemical indicator in healthy volunteers - a validation study for a novel technique.

Helsinki University Hospital0 sites12 target enrollmentOctober 22, 2020
DrugsPanadol

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Helsinki University Hospital
Enrollment
12
Status
Active, not recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 22, 2020
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Helsinki University Hospital

Eligibility Criteria

Inclusion Criteria

  • Informed consent. Healthy, normal weight, age 18\-45\. Must pass medical examination prior to inclusion.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 12
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Not considered healthy.
  • Alcohol, tobacco, or illegal substance use.
  • Regular medication incl contraceptives
  • Pregnancy, planned pregnancy or lactation
  • Participation in another clinical trial within 3 monts
  • Blood donation within 3 monts.
  • BMI \< 18\.5 or \> 30

Outcomes

Primary Outcomes

Not specified

Similar Trials